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When T cells recognize a peptide-major histocompat-
ibility complex on antigen-presenting cells (APCs),
T cell receptor microclusters (TCR-MCs) are gener-
atedandmove to thecenterof theTcell-APC interface
to form the central supramolecular activation cluster
(cSMAC). cSMAC formation depends on stimulation
strength and regulates T cell activation. We demon-
strate that the dynein motor complex colocalized
and coimmunoprecipitated with the TCR complex
and that TCR-MCs moved along microtubules (MTs)
toward the center of the immune synapse in a
dynein-dependent manner to form cSMAC. MTs are
located in close proximity to the plasma membrane
at the activation site. TCR-MC velocity and cSMAC
formation were impaired by dynein or MT inhibitors
or by ablation of dynein expression. T cells with
impaired cSMAC formation exhibited enhanced
cellular activation including protein phosphorylation
and interleukin-2 production. These results indicate
that cSMAC formation by TCR-MC movement
dependsondynein andMTs, and themovement regu-
lates T cell activation.
INTRODUCTION
After a T cell recognizes antigenic peptide in complex with the
major histocompatibility complex (pMHC) on an antigen-pre-
senting cell (APC), a specialized structure termed the immuno-
logical synapse (IS) forms at the interface. The IS allows for align-
ment of molecules in concentric rings at the intercellular contact
face. The cSMAC is formed by the T cell receptor (TCR) on the
T cell and the pMHC on the APC and the peripheral SMAC
(pSMAC) surrounding the cSMAC contains integrins (Grakoui
et al., 1999; Krummel et al., 2000; Monks et al., 1998). However,
immediately after pMHC recognition and prior to formation of thecSMAC, hundreds of TCR-MCs containing TCR and signaling
molecules, including kinases and adaptor proteins, are gener-
ated and function as a signalsome to transduce the initial signals
for T cell activation (Bunnell et al., 2002; Campi et al., 2005; Saito
and Yokosuka, 2006; Yokosuka et al., 2005). Within several
minutes after their initial generation, all the TCR-MCs move
toward the center of the contact site and generate the cSMAC.
The TCRs are then internalized at the cSMAC and TCR signaling
is terminated. This sequence of events is postulated based on
the finding that tyrosine phosphorylation of signaling molecules
is mainly observed at the periphery and is barely detectable
at the cSMAC, although protein phosphorylation has been
detected at the cSMAC under some conditions (Cemerski
et al., 2008; Yokosuka et al., 2005). The TCR-MCs are generated
continuously at the periphery, resulting in a sustained activation
signal. Therefore, the TCR-MCs translocation from the periphery
to the central regionmaintains a balance between the generation
of new TCR-MCs and their degradation at the cSMAC and thus is
critical in sustaining T cell activation (Varma et al., 2006; Yoko-
suka et al., 2008).
The centripetal movement of TCR-MCs has been shown to
depend on F-actin retrograde flow (Ilani et al., 2009; Kaizuka
et al., 2007). In this well-characterized process, lamellipodium
are extended at the leading edge by continuous actin-polymeri-
zation, whereas the initially polymerized F-actin flows in the
opposite direction, from the leading edge to the cell body
(Schaefer et al., 2008). Because the movement of TCR-MCs is
impaired by inhibition of Myosin II or actin polymerization, it
was suggested that the translocation of TCR-MCs depends on
F-actin retrograde flow. However, recent analyses clearly
showed that the area of F-actin flow is restricted to the periphery
of the contact site in Jurkat T cells (Yu et al., 2010). Thus, we
hypothesized that there is another mechanism besides actin
flow to transport TCR-MCs inside of the lamellipodium to
generate the cSMAC.
From the point of view of cytoskeletal regulation of TCR activa-
tion, the translocation of the microtubule (MT) organizing center
(MTOC) to the activation site is a well-known phenomenon
(Geiger et al., 1982), and this translocation occurswithin aminute
as one of the early activation markers. The cSMAC is alwaysImmunity 34, 919–931, June 24, 2011 ª2011 Elsevier Inc. 919
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Figure 1. Colocalization of the Dynein Complex with TCR-MCs
(A) Colocalization of the dynein complex with TCR-MCs. AND-Tg T cells expressing either DLC1-GFP, DIC2-GFP or Dctn1-GFP were placed on a planer bilayer
and fixed at 2 or 5 min after cell addition to the bilayer. The images of GFP and anti-CD33 staining were taken by confocal microscopy. Scale bars represent
2.5 mm.
(B) Kymographs of DLC1-GFP and H57Fab staining of AND-Tg T cells were taken by dual wavelength TIRF microscopy (see also Movie S1). Sequential image
sections per 2.5 s for 2 min are shown in chronological order. The scale bar represents 2.5 mm.
(C) Coimmunoprecipitation of the dynein and CD3 complexes. Cell lysates of AND-Tg T cells activated with MCC peptide-loaded DC1 cells were immuno-
precipitated with anti-CD33, and blotted with Abs against the indicated proteins. Hamster IgG1/k was used as the control.
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Dynein Transports TCR Microclustersgenerated in the vicinity of the translocated MTOC. It was
reported that dynein, a minus-end MT motor protein, mediates
the translocation of the MOTC in Jurkat cells (Combs et al.,
2006). According to several studies, dynein becomes trapped
at the distal SMAC (dSMAC) through the association with adhe-
sion and degranulation promoting adaptor protein (ADAP), and
this was speculated to pull MTs to translocate the MTOC to
the activation site (Combs et al., 2006; Martı´n-Co´freces et al.,
2008). It was also reported that the accumulation of diacylgly-
cerol (DAG) and dynein induced MTOC translocation in normal
T cells (Quann et al., 2009).
In this study, we show that the movement of TCR-MCs toward
the center of the IS depends on the activity of dynein. In primary
T cells, dynein complex proteins formed clusters at the TCR-
MCs, associated with the TCR complex, and then moved
together with TCR-MCs. Time-lapse imaging of MTs and TCR
showed that the TCR-MCs move along MTs. Inhibition of dynein
function or MTs assembly by inhibitors or specific ablation of
dynein expression impaired TCR-MC movement and cSMAC
formation without affecting the generation of TCR-MCs. Conse-
quently, cellular activation was increased in these T cells. These
results suggest that TCR-MCs move along MTs in a dynein-
dependent manner and that this centripetal movement regulates
T cell activation through enhancing TCR-MC motility to ulti-
mately terminate signaling activity.920 Immunity 34, 919–931, June 24, 2011 ª2011 Elsevier Inc.RESULTS
Colocalization and Association of TCR-MCs with the
Dynein Complex
T cell activation on a planar bilayer containing GPI-anchored
forms of ICAM-1 and I-Ek loaded with Moth cytochrome C
(MCC) peptide enabled us to observe formation and centripetal
movement of TCR-MCs (Yokosuka et al., 2005). The direction
of the movement strongly suggests the involvement of minus-
end-directedmotor proteins. Therefore, we examined the dynein
complex of MT motor proteins (Kardon and Vale, 2009). AND-
transgenic (Tg) T cells were transfected with GFP-labeled
dynein light chain-1 (DLC1, LC8) (DLC1-GFP), dynein interme-
diate chain-2 (DIC2-GFP), and dynactin-1 [Dctn1, p150(Glud)]
(Dctn1-GFP), placed on the planer bilayer, fixed at 2 or 5min after
cell addition, and analyzed by confocal microscopy. Surpris-
ingly, all three molecules colocalized with TCR-MCs at the time
of initial activation and with the cSMAC after its formation later
(Figure 1A), suggesting that the dynein complex is colocalized
with TCR-MCs and translocated together with TCR-MCs into
the center of the IS. The kymograph of DLC1-GFP and TCR
stained with a Fab fragment of anti-TCRb (H57Fab) at the initial
phase revealed that the DLC1-GFP cluster and the TCR-MCs
were generated simultaneously and moved together to the
cSMAC (Figure 1B, Movie S1 available online). The association
Immunity
Dynein Transports TCR Microclustersof TCR and the dynein complex was also demonstrated by
biochemical analysis. AND-Tg T cells were activated by conjuga-
tion with MCC peptide-loaded DC1 cells. Cell lysates were
immunoprecipitated with anti-CD33 and blotted for CD3, associ-
ated molecules, and the dynein complex. Coimmunoprecipita-
tion of Dctn1 and dynein heavy chain (DHC) with CD33, CD3z,
and ZAP70 was clearly observed, and the association of the
CD3 and dynein complexes was increased upon stimulation
(Figure 1C). These results indicate that the dynein complex
becomes associated with the TCR signaling complex upon
activation.
Translocation of TCR-MCs along Microtubules
Because dynein is a MT motor transporting target cargos along
MTs, we analyzed the direct relationship between TCR-MCs and
MTs. GFP-labeled a-tubulin (GFP-tubulin) was expressed in
AND-Tg T cells to visualize MTs, and the TCR complex was visu-
alized by expression of Halo-tag-conjugated CD3z (CD3z-Halo).
Because MTs are located inside of the plasma membrane, they
are visualized in the same focus with TCR-MCs only when they
are in close proximity to the membrane. MTs were radiated
from the MTOC, which located very close to the plasma
membrane. When the attached T cells begin to contract, the
TCR-MCs moved along the MTs toward the center of the inter-
face and accumulated around the MTOC to form a cSMAC
(Figure 2A; Movie S2). We made movies of GFP-tubulin and
H57Fab-staining by using TIRF microscopy with high resolution
of time and x-y dimensions. The movement of individual TCR-
MC along MTs was clearly visualized in the enlarged sequential
images in Figure 2B and in Movie S3. Colocalization of TCR-
MCs and MTs was quantified by staining fixed cells. To obtain
high-resolution images of tubulin, we analyzed the MTs stained
by anti-b-tubulin-FITC with confocal microscopy using STED
beam (Figure 2C). Approximately 60%–90% of TCR-MCs were
colocalized with MTs at the initial stimulation phase. To validate
the colocalization statistically, we compared the frequency
between MT and TCR-MCs versus geometric dots (Figure 2C).
Tomimic uniformly distributed TCR-MCs, we adjusted the diam-
eter of the geometric dots to the diameter (±2 SD) of the average
TCR-MC, and the number of dots was based on that of TCR-
MCs per cell. The images of TCR-MCs and geometrical dots
were counted automatically with G-count software (Figure S1A),
and the ratio of total TCR-MCs (or dots) versus TCR-MCs (or
dots) colocalized with MTs were plotted for each cell. These
results showed significantly higher frequencies of colocalization
of TCR-MCs with MTs than the dots (Figure 2C, rightmost). AND
T cell hybridomas, which have a higher density of MTs, were also
analyzed and obtained similar results (Figure S1B). We also
compared colocalization in the peripheral (phalloidin staining)
versus inner areas. The proportion of the TCR-MCs colocalized
with MTs was higher in the inner area than in peripheral F-actin
area (Figure S1C). Therefore, MT-mediated translocation of
TCR-MCs may function at the central region rather than in the
periphery, suggesting that the initial movement of newly gener-
ated TCR-MCs in the early activation phase depends on F-actin
retrograde flow and later movement of TCR-MCs to the center to
form a cSMAC depends on MTs.
Because MTs exhibit dynamic lateral movement, a TCR-MC
shouldmeander vertically toward the center of the cell if it movesalong only one MT. Precise analysis of the movies of TCR-MC
movement revealed that the TCR-MC switches ‘‘tracks’’ to asso-
ciates with another MT when a new one approaches andmerges
when in close proximity (Figure S1D and Movie S4). Therefore,
TCR-MCs assemble with and move along more than one MT
to reach the cSMAC.
To determine the dynamics of colocalization, we took movies
of MTs (GFP-tubulin) and TCR-MCs (H57Fab) from the time of
initial attachment (Figure S1E and Movie S5). When cells began
to spread after attachment to the planar bilayer, a few TCR-MCs
and MTs were detected. By 30 s, T cells displayed maximum
spreading and the MTOC had translocated close to the
membrane at the activation site of the T cell-bilayer interface.
There was readily detectable radiation of the MTs from the
MTOC, and TCR-MCs moved along MTs and formed the
cSMAC around the MTOC (Figure S1E, top). Reconstructed 3D
images of tubulin and the TCR demonstrated that the MTOC
translocated to the contact site as quickly as 2 min after cell
addition and was localized just behind the cSMAC (see below).
In the cells exhibiting delayed (or no) MTOC translocation,
cSMAC formation was also delayed (or not observed) (Fig-
ure S1E, middle and bottom). Analyzing a time course, from
the first appearance of TCR-MCs and MTOC localization until
cSMAC formation, we found that MTOC relocation and cSMAC
formation was correlated and that cSMAC was hardly ever
detected without MTOC relocation. Moreover, the times to
cSMAC formation and MTOC appearance were positively cor-
related (Figure S1E, right). These results suggest that the direc-
tion of TCR-MC movement depends on MTOC translocation.
We examined the signaling status of the TCR-MCs on MTs by
staining tyrosine-phosphorylated proteins. AND-Tg T cell hybrid-
omas were stimulated on the planar bilayer and stained for
b-tubulin, CD33 and phospho-CD3z (pCD3z), phospho-ZAP70
(pZAP), or phospho-SLP-76 (pSLP) (Figure 2D; Figure S1F).
Most of the clusters of these phospho-proteins within TCR-
MCs were colocalized with MTs. The colocalization of phospho-
proteins with MTs was confirmed by comparison with geometric
dots, similar to the analysis in Figure 2B (Figure 2D, rightmost).
These data suggest that most, if not all, the TCR-MCs moving
along MTs contain active signaling complexes.
Lateral Movement of TCR-MCs on the Plasma
Membrane
Because dynein generally functions in the intracellular space,
and it has been suggested that TCR-MCs move laterally on the
plasma membrane (Mossman et al., 2005), we tested our hy-
pothesis of dynein-mediated lateral movement of the TCR-MC
on the cell surface by using five approaches. First, we deter-
mined whether inhibition of dynamin-dependent internalization
affected the TCR-MCs and the cSMAC, although we notice
that not all of the endocytic pathway requires dynamin (Bitoun
et al., 2007). Whereas pretreatment of activated T cells with the
dynamin inhibitor Dynasore inhibited internalization of tetraspa-
nin CD63, whose internalization is known to be dynamin-depen-
dent (Pols and Klumperman, 2009), Dynasore had no effect on
the number or intensity of TCR-MCs or on cSMAC formation (Fig-
ure S2A). Similarly, overexpression of a dominant-negative (DN)
form of dynamin K44A, which has lost the GTPase activity
required for endocytosis, had no significant effect in the numberImmunity 34, 919–931, June 24, 2011 ª2011 Elsevier Inc. 921
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Dynein Transports TCR Microclustersor intensity of TCR-MCs and cSMAC formation (Figure S2B). The
DN effect of dynamin (K44A) was confirmed by its ability to
enhance the cell surface expression of CD63 by inhibiting its
internalization. These data suggest that the generation and
translocation of TCR-MCs are independent of dynamin-medi-
ated endocytosis. Second, we analyzed the distribution of the
amphiphilic styryl dye FM4-64, which stains cell membranes
and is used for internalization. In CD3z-GFP-expressing T cells
activated on a planer bilayer in the presence of FM4-64, FM4-
64 accumulation was observed at the cSMAC but not at
TCR-MCs (Figure S2C). Third, the cell surface and intracellular
TCR-MCs were distinguished by sequential staining, first with
anti-CD33 before fixation to detect the cell surface TCR (CD33
out) and then with another Abs for CD33 and b-tubulin after fixa-
tion and permeabilization for detection of all TCR (CD33 all).
These images revealed that some TCR-MCs around MTOC
were detectable only after permeabilization, whereas the cluster
numbers and the percentages of TCR-MCs colocalized withMTs
were unchanged between CD3 (all) and CD33 (out) (Figure S2D,
right), demonstrating that the majority of the TCR-MCs are
present on the cell surface at the initial activation phase. Fourth,
we confirmed that the TCR-MCs stained from outside of the
plasma membrane can be quenched by a membrane imper-
meant quencher, 2,4,6-trinitrobenzene sulfoic acid (TNBS)
(Wolf, 1985). AND hybridoma T cells expressing CD3z-Halo as
intracellular fluorescence and stained with H57Fab-DyLight488.
Whereas the fluorescence of CD3z-Halo was unchanged by the
addition of TNBS, that of H57Fab stainingwas almost diminished
immediately after TNBS addition (Figure S2E). Fifth, AND-Tg
T cells stimulated by MCC peptide-loaded DC1 cells were
surface-biotinylated and the cell lysates were immunoprecipi-
tated with streptavidin-beads and blotted for the dynein com-
plex proteins (Figure S2F). The dynein complex proteins DHC
and Dctn1 were coprecipitated with cell surface proteins. The
amount of dynein proteins associated with cell surface mole-
cules was increased upon TCR activation, suggesting that the
dynein complex accumulates at the cell surface during this
process. Collectively, these results suggest that most of the
TCR-MCs are translocated by dynein andMT on the cell surface,
although we cannot completely rule out the possibility that a few
clusters are internalized and transported intracellularly.
To understand the structural basis of the lateral movement of
the TCR complex on MTs by dynein-mediated force, we deter-
mined whether the MTs are close enough to directly interact
with the TCR complex via the dynein complex. To this end, weFigure 2. Translocation of TCR-MCs along MTs
(A) AND-Tg T cells expressing GFP-tubulin and CD3z-Halo were examined on a p
formation were taken every 7.5 s (see also Movie S2). Relative time scales star
represents 2.5 mm.
(B) AND-Tg T cells expressing GFP-tubulin and stained with H57Fab were exami
right panel was clipped (see also Movie S3) and rearranged in chronological orde
represents 1.0 mm.
(C) Comparison of the colocalization between TCR-MCs and geometric dots with
and stained for CD33 and tubulin. STED beam was used for observing FITC-tubu
dots and MTs (41.8% ± 14.2%, dots with MTs) were shown. The ratio of total TCR
colocalized with MTs (dots) were plotted for each cell (see also Figure S1A). The
(D) Colocalization of phosphorylated signaling molecules with MTs. AND T cell hy
and stained for btubulin, CD33, pCD3z, pZAP, or pSLP. The ratio of the clusters o
(C) and plotted for each cell (right panels) (see also Figure S1F). Scale bars repredetermined the distance between the MTs and the plasma
membrane at activation and nonactivation sites by electron
microscopy and plotted it (Figure 3). At the activation sites, we
detected many MTs localizing within 50 nm at the proximity of
the plasma membrane, whereas MTs were not observed at
such proximity at the nonactivation sites. Considering themolec-
ular size of the dynein complex, which is 30 nm for dynein and
24 nm for dynactin (Burgess et al., 2003; Kardon and Vale, 2009),
the distance of 50 nm would be close enough to assemble MTs
and the plasma membrane via protein clusters of the dynein
complex and TCR signaling molecules. These results indicate
that TCR-MCs move on the cell surface along the MTs localized
just beneath the plasma membrane.
Inhibition of TCR-MC Movement and cSMAC Formation
by Inhibitors of Dynein and Microtubules
Next, we examined the effect of pharmacological inhibitors of
dynein and MTs on TCR-MC translocation. We established
CD3z-GFP gene-targeted (zGFP-gT) mice to analyze the
dynamics of the endogenous TCR-CD3 complex (Figure S3).
zGFP-gT AND-Tg T cells were pretreated with inhibitors of the
dynein ATPase, EHNA (Bouchard et al., 1981), and of tubulin
polymerization, nocodazole (Noco) or colchicine (Col). Concen-
trations of the inhibitors were chosen not to inhibit TCR activation
(Huby et al., 1998), and the disruption of MT by Noco-and Col
treatment was confirmed (Figure 4C). T cells pretreated with
these inhibitors were placed on a planer bilayer and the
dynamics of TCR-MCs were analyzed by TIRF microscopy.
None of the inhibitors affected the generation of TCR-MCs;
however, the formation of the cSMAC by translocation of TCR-
MCs toward the center of the contact region was clearly inhibited
by all inhibitors (Figure 4A; Movie S6). The average velocity of
newly generated TCR-MCs at the periphery around the time of
maximum cell spreading was analyzed by ImageJ and represen-
tative traces are shown in Figure 4A. In normal T cells, the
average initial velocity was 251 ± 151 nm/s, gradually decreased
with time, and the majority reached cSMAC and lost velocity
within 1 min. By contrast, the initial velocity in T cells treated
with the inhibitors was reduced by more than 40% (163 ±
156 nm/s for EHNA, 151 ± 108 nm/s for Noco, 127 ± 99 nm/s
for Col) and gradually decelerated (Figure 4B, rightmost). To
clarify the basis of the initial velocities by dynein- and MT- inhib-
itors (Figure 4B), we plotted individual initial velocities of TCR-
MCs within 2.0 s (Figure S4A). TCR-MCs with a higher velocity
(>400 nm/s) were observed only in the control cells, whereaslanar bilayar. Sequential images of TCR-MC movement along MT and cSMAC
ting from the time of cell spreading are labeled on the images. The scale bar
ned by TIRF microscopy with higher resolution. The area of white square in the
r (left panels). A representative TCR-MC is indicated by arrows. The scale bar
MTs. AND-Tg T cells on a planer bilayer were fixed at 1 min after cell addition
lin. Colocalization images of CD33 and MTs (70.6% ± 9.6%, MCs with MTs) or
-MCs versus TCR-MCs colocalized with MTs (CD33) and total dots versus dots
scale bar represents 2.5 mm; **p < 0.001.
bridoma cells were placed on a planer bilayer, fixed at 2 min after cell addition,
f pCD3z, pZAP, or pSLP colocalized with MTs were analyzed similarly to that in
sent 1.0 mm; **p < 0.001.
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Figure 3. Electron Microscopic Analysis of
the Distance between the MT and the
Plasma Membrane
Representative images taken from the activated
and nonactivated sides of AND-Tg T cells on a
planer bilayer are shown. Open and closed arrows
indicate MT and plasma membrane, respectively.
The distance taken from 114 positions in 23 cells
for the activated side (act.) (mean ± SEM is 137.3 ±
117.7 nm) and 51 positions in 16 cells for the non-
activated side (non-act.) (192.8 ± 125.4 nm) are
plotted in the right panel; *p < 0.05.
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Dynein Transports TCR Microclustersthose with a lower velocity were observed in both control and
inhibitor-treated T cells. Thus, higher velocity TCR-MCs in
control T cells may contribute to the observed increased average
velocity and probably depend on dynein activity along MTs,
given that they disappeared in the dynein or MT-inhibitor-treated
cells (Figure S4A). Accordingly, we analyzed the distribution of
MTs at the periphery (Figure S4B), the staining of MTs, and
clearly confirmed that MTs also exist in the peripheral region
and interacted with TCR-MCs. These results suggest that there
are TCR-MCs moving along MT toward the center, although
the F-actin retrograde flow mainly functions for initial transport
TCR-MCs from the periphery.
We also analyzed the effect of these inhibitors on actin poly-
merization because the destruction of F-actin could affect the
velocity of TCR-MCs. T cells were stained for b-tubulin and
CD33 andwith phalloidin at 5min after the initial cell contact (Fig-
ure 4C, left). Analyzing fluorescent intensities and areas of phal-
loidin staining, we found no demonstrable effect of the inhibitors
on actin polymerization (Figure 4C, right). When GFP-actin was
imaged by TIRF microscopy, there was no difference between
normal and inhibitor-treated T cells in terms of actin clusters at
the initial phase and then on dense accumulation at the periph-
eral regions (Movie S7). These observations suggest that F-actin
retrograde flow-dependent TCR-MC movement is intact at the
peripheral regions where dynein and MT-polymerization were
blocked by the inhibitors.
Because it was suggested previously that MTOC translocation
in Jurkat cells depends on dynein function (Combs et al., 2006;
Martı´n-Co´freces et al., 2008), we determinedwhether the impair-
ment of TCR-MC movement and cSMAC formation in EHNA-
treated T cells was due to a blockade in MTOC translocation.
When EHNA-treated T cells were placed on a planer bilayer
and the dynamic movements of TCR and MTs were analyzed
by 3D reconstruction, the MTOC in EHNA-treated cells was
translocated to the immediate vicinity to the plasma membrane924 Immunity 34, 919–931, June 24, 2011 ª2011 Elsevier Inc.within 2 min after cell attachment (Fig-
ure 4D). Furthermore, we tested whether
the dynein and TCR complexes are still
associated in the presence of the dynein
and MT-inhibitors. When AND-Tg T cells
pre-treated with EHNA, Noco, or Col
were activated with MCC peptide-loaded
DC1 cells and the cell lysates were immu-
noprecipitated, Dctn1 and DHC were
similarly coprecipitated with CD3z andZAP70 in both control and inhibitor-treated T cells (Figure 4E),
suggesting that the association of the dynein complex and the
TCR complex is independent of dynein ATPase activity andMTs.
Specific Reduction of DHC Inhibits TCR-MC
Translocation and cSMAC Formation
The use of pharmacologic inhibitors can provide important
insights into biological processes; however, they may have off-
target effects; for example, EHNA inhibits phosphodierastase-2,
and Noco has been reported to block store-operated calcium
influx. Therefore, we analyzed the effect of dynein-specific abla-
tion by siRNA for DHC. zGFP-gT AND-Tg T cells were transfected
either with a DHC-specific (siDHC) or nonspecific control siRNA
(siCtrl), and DHC mRNA and protein expression in the siRNA-
transfected cells were measured. The siDHC reduced to 60% of
the mRNA expression specifically (Figure 5A). A reduction of
DHC protein to 49.9% of the control level in the siDHC-treated
cells was confirmed by western blotting (Figure 5A). The siRNA-
treated cells were placed on a planer bilayer and the movement
of TCR-MCs, cSMAC formation as well as the trajectory of TCR-
MCs was analyzed (Figures 5B and 5C; Movie S8). Quantitative
analysis of these images revealed that the cells with specific abla-
tion of DHC expression (siDHC-treated) formed almost the same
number of TCR-MCs and had the same fluorescence intensity
and size as those in the control cells. However, the velocities of
TCR-MCs and the proportion of the cells forming cSMAC were
significantly reduced in siDHC-treated cells (Figure 5D). Similar
to the inhibitor data in Figure 4B and Figure S4A, we observed
a reduction of TCR-MCs with higher initial velocity in siDHC-
treated cells compared to in control cells, confirming the involve-
ment of MTs for MC movement at the peripheral region (Fig-
ure S4B). The fluorescent intensity of the cSMACs was also
reduced in siDHC-treated cells, whereas the cSMAC radius was
significantly enlarged. The fact that the reduced DHC level to
approximately a half of the normal level resulted in the clear
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Figure 4. Inhibition of TCR-MC Translocation by Dynein or MT Inhibitors
(A) zGFP-gT AND-Tg T cells pre-treated with 1 mM EHNA, 1 mM Noco, 100 mM Col, or vehicle (Ctrl) for 30 min were taken images by TIRF microscopy on planar
bilayer (see also Movie S6). Representative sequential images and the trajectory (right panels) of individual TCR-MCswithin the initial 3 min are shown. Scale bars
represent 2.5 mm.
(B) Statistical analyses of TCR-MCs in their number, fluorescence intensity, and velocity, and the frequency of cSMAC formation in AND-Tg T cells treated with
EHNA (blue), Noco (red), Col (green), or Ctrl (black); *p < 0.01. Data are shown as average ± SD. See also Figure S4; *p < 0.01, **p < 0.001.
(C) Images of MTs and F-actin in T cells pretreated with the dynein and MT inhibitors upon stimulation on a planar bilayer. Staining of b-tubulin (green), phalloidin
(red), and CD33 (cyan) were imaged at 5 min after cell addition. The scale bar represents 2.5 mm. (right panel). Intensities of phalloidin staining at 1 min (closed) or
5 min (open) in T cells were plotted. Data represent the average ± SD.
(D) x-z images of MT and TCR in AND-Tg T cells pretreated with EHNA by stimulation on a planar bilayer (left panel). EHNA-treated or Ctrl T cells were stained for
b-tubulin (green) and CD33 (red) at 2 min after cell contact. Five representative cells for each condition are shown. Statistical analysis exhibited MTOC trans-
location to the activation site (right panel). Scale bars represent 5.0 mm. Data represent the average ± SD.
(E) Coprecipitation of the dynein complex with the CD3 complex from T cells pretreated with the dynein or MT inhibitors. Cell lysates of the inhibitor-treated AND-
Tg T cells after activation by MCC peptide-loaded DC1 cells were immunoprecipitated with anti-CD33 and blotted with Abs against CD3z, ZAP, Dctn1, and DHC.
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Figure 5. Inhibition of TCR-MC Movement by DHC Ablation
(A) Expression of DHC in zGFP-gT (see also Figure S3) AND-Tg T cells transfectedwith siDHC (open) or siCtrl (closed) wasmeasured by semiquantitative RT-PCR
(CD3z as control) and blotted with anti-DHC (tubulin as control). Data represent the average ± SD; **p < 0.001.
(B and C) The dynamics of TCR-MCs in siDHC-treated T cells examined by TIRF microscopy (Movie S8). Representative trajectory (B) and the sequential images
(C) of TCR-MCs movement are shown. See also Figure S4. Scale bars represent 2.5 mm.
(D) Statistical analyses of TCR-MCs in the number, fluorescence intensity, and velocity and the frequency and fluorescence intensity of cSMAC in siDHC-treated
T cells (red dot, open bar) or control cells (black dot, closed bar). See also Figure S4. Data represent the average ± SD; a.u., arbitrary unit; *p < 0.01.
(E) Images of MTs and F-actin in the siDHC-treated T cells on a planar bilayer. siDHC-treated T cells or control cells were fixed 10 min after cell addition and
stained for b-tubulin (green), phalloidin (red), and CD33 (blue). (right): Intensities and areas of phalloidin staining at 2 or 10 min in siCtrl (closed)- or siDHC (open)-
treated T cells were plotted. Scale bars 2.5 mm. Data are average ± SD.
(F) x-z images of MT and TCR in the siDHC-treated T cells. The T cells on a planar bilayer were fixed at 5 min after cell addition, and stained for b-tubulin (green)
and CD33 (red). Four representative cells for each are shown. Shown on the right is the statistical analysis of MTOC translocation to the activation site in the left
images. Scale bars represent 5.0 mm. Data represent the average ± SD.
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Dynein Transports TCR Microclustersinhibition of cSMAC formation might suggest a certain threshold
of DHC or the dynein complex required for the translocation of
TCR-MCs. However, these results are consistent with those
from the inhibitor studies, indicating that the ablation of DHC
expression results in decreased TCR-MC motility, consequently
impairingcSMACformation,withoutalteringTCR-MCgeneration.
We observed no difference in phalloidin intensities (Fig-
ure 5E) and GFP-actin images (Movie S9) between control926 Immunity 34, 919–931, June 24, 2011 ª2011 Elsevier Inc.and siDHC-treated T cells during the early time course after
cell contact. Analysis of MTOC translocation in control or
siDHC-treated cells by 3D reconstruction (Figure 5F) demon-
strate that F-actin polymerization at the periphery and MTOC
translocation to the region in close proximity to the plasma
membrane were intact in siDHC-treated cells and that
the reduction of dynein resulted in the inhibition of cSMAC
formation.
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Figure 6. Impaired T Cell Activation Signals in DHC-Ablated T Cells
(A) siDHC-treated AND-Tg T cells (siDHC) or control cells (siCtrl) on a planar bilayer were fixed and stained for CD33, pY, pCD3z, or pLAT at 1 or 5 min after cell
addition. Representative images are shown. Scale bars represent 2.5 mm.
(B) The cluster numbers or intensities of the indicated phospho-proteins (pY), phospho-CD3z, and phospho-LAT in siDHC-treated (open)- and control (closed)
T cells from the images in (A) are plotted. Data represent the average ± SD; *p < 0.01.
(C) Immunoblot analysis of phospho-LAT (pLAT) and phospho-Erk (pErk) in siDHC-treated T cells. AND-Tg T cells were stimulated by MCC-loaded DC1 cells.
LAT, Erk, and tubulin were blotted as controls. As shown on the right, the relative intensities of pLAT versus LAT and pErk versus Erk in siDHC-treated (open) or
siCtrl (closed)-treated cells from three independent experiments are indicated. Data represent the average ± SD; *p < 0.05.
(D) Functional consequence of DHC ablation in T cells. siDHC-treated (open) or control (closed) AND-Tg T cells were stimulated with graded concentrations of
MCC or PMA plus ionomycin. IL-2 levels in the supernatants were measured by ELISA 24 hr after stimulation. Error bars are SD of triplicate cultures. Data are
representative from four experiments and are shown as average ± SD; *p < 0.05, **p < 0.01.
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We next analyzed the functional effects of siDHC treatment on
T cell activation. The signaling status of the T cells activated on
a planar bilayer was analyzed for total tyrosine phosphorylation
(pY) as well as specific phosphorylation of CD3z (pCD3z) and
LAT (pLAT) (Figure 6A). The phosphorylated protein clusterswere similarly induced in both siDHC-treated and control
T cells during the initial activation at 1 min after cell addition.
However, more clusters remained in the siDHC-treated cells
than in the control cells at 5 min (Figures 6A and 6B). Similarly,
the clusters of pCD3z and pLAT were induced equivalently in
siDHC-treated and control cells during the initial activation;Immunity 34, 919–931, June 24, 2011 ª2011 Elsevier Inc. 927
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Dynein Transports TCR Microclustershowever, more clusters remained in the siDHC-treated cells than
the control cells at a later stage (5 min) (Figures 6A and 6B).
Downstream signaling events such as LAT phosphorylation
(pLAT) and Erk phosphorylation (pErk) upon stimulation with
peptide-pulsed DC1 cells were also examined by western blot-
ting. The siDHC-treated T cells exhibited stronger phosphoryla-
tion of both pLAT and pErk than control cells (Figure 6C). Consis-
tently, IL-2 production (Figure 6D) and cell growth (data not
shown) after 24 hr stimulation with peptide APC were signifi-
cantly enhanced in siDHC-treated cells as compared with
control cells. Collectively, these results indicate that dynein-
driven TCR-MC movement enhances internalization and termi-
nation of TCR-MC signaling at the cSMAC.
DISCUSSION
In this study, we demonstrated that the movement of TCR-MCs
depends on the minus-end-directed MT motor protein dynein.
The translocation from the periphery and ultimate degradation
at the cSMAC attenuates TCR signaling by reducing the number
of signaling competent TCR-MCs. These findings revealed an
unknown function for dynein as a negative regulator of TCR
activation.
The present study supports the idea that TCR-MCs are trans-
ported bymechanisms that depend on both actin retrograde flow
and the MT network. The fact that inhibition of actin polymeriza-
tion leads to a complete block of TCR-MCmovement (Ilani et al.,
2009) clearly indicates that actin polymerization is essential for
launching the TCR-MCs. However, under conditions of attenu-
ated dynein activity or in the absence of the MT network, TCR-
MCs velocities, probably by actin retrograde flow, were reduced
and cSMAC formation was inhibited, indicating that cSMAC
formation requires both actin- and MT-mediated movement of
TCR-MCs. It is likely that actin-dependent movement is required
for initiation of the TCR-MC translocation, and then dynein-
driven MT-dependent movement is utilized to increase the
velocity and generate the cSMAC. Cooperation of both actin
and MT to regulate T cell activation was also reported for cyto-
skeletal and MT network regulation (Lasserre et al., 2010).
TCR-MCs appeared to move along more than one MT during
their journey to the cSMAC. MT moved continuously and dynam-
ically, sometimesmovingoutof theareadetectablebyTIRF,which
is very close to membrane. When MTs moved to the inside of the
cells, the TCR-MCs on the MT appeared to become uncoupled,
probably because of the relatively weak association, and the
TCR-MCs associated with another MT in close proximity. Even
during the period when they are uncoupled with MT, the TCR-
MCs do not move backward, probably because of the constant
inward pressure caused by actin-mediated flow at the periphery.
Such discontinuous movement along MT has been shown during
dynein-mediated transfer transferrin receptors inHeLa cells (Traer
et al., 2007) aswell as during vesicular transport in neuronal axons
where MT are discontinuous and MTmotors wander among MTs
tomove a long distance (Yu andBaas, 1994). It is likely that dynein
functions in trafficking of TCR-MCs for T cell activation because
their movement was inhibited by EHNA and ablation of DHC
expression. However, considering that the dynein complex is
assembled with the TCR signaling complex including the TCR-
CD3 complex, ZAP-70 and LAT, it is possible to propose that928 Immunity 34, 919–931, June 24, 2011 ª2011 Elsevier Inc.dynein also has an assembling or signaling function for T cell acti-
vation. As for membrane proximal assembly, we detected the MT
close to the plasma membrane, within 50 nm at only the acti-
vation sites. The molecular sizes of the dynein complex and the
TCR proximal signaling complex of TCR/CD3-ZAP70-LAT-Grb2-
SLP76 could be estimated from the data of crystal structures
and simulation to be more than 50 nm (Burgess et al., 2003; Call
et al., 2006; Deindl et al., 2007; Nag et al., 2009); thus the distance
between themembrane and theMTestimated fromEManalysis is
small enough toallowdirect interactionbetween theTCRsignaling
complex and the dynein complex.
The molecules responsible for the connection between the
TCR complex and the dynein complex remained to be deter-
mined. There are a few reports suggesting that the molecules
involved in this connection include ADAP and intraflagellar trans-
port protein 20 (IFT20). It was shown that ADAP is co-precipi-
tated and colocalized with DIC at the IS in Jurkat T cells (Combs
et al., 2006). Moreover, IFT20 is recently shown to be required for
polarized TCR recycling to the IS and associates with CD3
chains upon T cell activation (Finetti et al., 2009). Because IFT
transport requires dynein or kinesin in flagella (Pazour et al.,
1998), it is possible that IFT20 could associate with the CD3
chains in activated T cells and then recruit the dynein complexes.
The molecular mechanism underlying the assembly between the
TCR and dynein complexes remains to be established.
Dynein-dependent MTOC translocation and reorientation has
been shown in mitosis, cellular migration, and cellular activation,
particularly in T cells and macrophages (Eng et al., 2007; Martı´n-
Co´freces et al., 2008; Robinson et al., 1999). It was recently sug-
gested that DAG localization followed by dynein accumulation at
the activation site could pull the MTOC in T cells (Quann et al.,
2009), thus colocalization of the dynein complex with TCR-MCs
might serve to translocate the MTOC toward the activation site.
However, because the dynein-inhibitor and dynein ablation had
little effect on MTOC translocation in our studies, MTOC move-
ment may result from residual dynein activity. Consistent with
this idea, Jenkins et al. (2009) showed that stimulation with
a low-avidity antigen, which failed to induce granule polarization,
could nonetheless recruit theMTOC to the activation site in cyto-
toxic T cells.
There are numerous reports describing dynein-mediated
transport of receptors, such as the neurotrophin receptor (Trks)
(Heerssen et al., 2004; Yano et al., 2001), the epidermal growth
factor receptor (Driskell et al., 2007), and the N-methyl d-aspar-
tate (NMDA) receptor (Valtschanoff and Weinberg, 2001). Of
particular relevance, Trk B is transported in a phosphorylated
state, similar to the TCR-MCs. However, all of these receptors
have already been internalized and are then transported along
MTs by dynein. To our knowledge, there has been no description
until now of dynein–mediated lateral movement of a cell surface
receptor on the plasma membrane. However, the conclusion
that TCR-MCs move on the cell surface is supported from
multiple perspectives from our data and a report from Mossman
et al. (2005). Our finding of dynein-mediated lateral movement of
a cell surface receptor complex would have general importance
in how we view dynein functions.
We showed that TCR-MCs onMTswere accompanied by acti-
vated signalingmolecules. It has been shown in Jurkat cells stim-
ulated with immobilized TCR Abs that the SLP-76-containing
Immunity
Dynein Transports TCR Microclusterssignaling complex moves on MTs or F-actin (Barr et al., 2006;
Nguyen et al., 2008). The movement of the SLP-76 complex on
MTs was essential for its activity because disruption of the MT
network by ablation of Ezrin expression resulted in impaired
movement of the SLP-76 clusters and enhanced cellular activa-
tion (Lasserre et al., 2010). Despite the different experimental
system from that used in our study, theconcept that translocation
of the active signaling clusters along MT regulates T cell function
as a negative regulator of cellular activation is consistent.
The function of the cSMAC was proposed initially to mediate
activation signals, but later to regulate internalization and degra-
dation of the TCR complex, and then it was also suggested to
inhibit strong stimulation (Cemerski et al., 2008; Vardhana
et al., 2010; Varma et al., 2006). In this study, we compared
the function of T cells with normal and partially impaired
cSMAC formation that had both received the same strength of
stimulation and found that the inhibition of TCR-MC movement
results in enhanced activation, suggesting a critical function of
TCR-MC transport in inhibiting T cell activation through the
reduction of TCR-MCs and enhanced degradation in the
cSMAC. A similar mode of regulation was demonstrated in
T cells deficient in CD2AP and with ablation of TSG101 expres-
sion. In CD2AP-deficient T cells, the inhibition of TCR sorting and
degradation after internalization at cSMAC resulted in dysregula-
tion of TCR signaling (Lee et al., 2003). This machinery for the
internalization and degradation would function after dynein-
driven TCR-MC movement into cSMAC. Inhibition of cSMAC
formation by ablation of TSG101 also resulted in enhanced
T cell activation, probably through the similar mechanism as
CD2-AP-deficient T cells (Vardhana et al., 2010). When T cells
receive a weak stimulus, no cSMAC is generated and TCR-
MCs remain at the periphery without moving to the center.
T cells may not require negative regulation through the cSMAC
after such a weak stimulus. Collectively, the dynamic movement
of TCR-MCs from the periphery to the center of the immune
synapse for cSMAC generation and degradation may regulate
T cell responsiveness in a signal strength-dependent fashion.
How the signal strength can discriminate and regulate the
assembly and/or transport of the TCR-signaling complex by
the dynein complex has to be determined.
In B cells, the B cell receptor (BCR) also forms MCs together
with signaling molecules which move to the center upon antigen
recognition (Depoil et al., 2008). The accompanying manuscript
by Schnyder et al. (2011) in this issue of Immunity shows that
dynein is also a component of the BCR-associated signaling
protein complex that mediates BCR-MC transport and that the
MT network also has a critical role in regulating B cell activation.
Thus, the dynein-mediated movement of the antigen receptor
complex, which regulates consequent cellular activation, is
a common mechanism in lymphocytes, and further dynamic
regulation of other surface receptors by dynein-mediated trans-
port may be a general mechanism in other cell types.EXPERIMENTAL PROCEDURES
Mice and Cells
AND-Tg mice were provided by R.N. Germain (National Institutes of Health,
MD); B10.BR from Japan SLC Inc. The DC line (DC-1) was provided by J.
Kaye (La Jolla, CA).Planar Bilayer System
GPI-anchored Mouse MHC class II molecule I-Ek and ICAM-1 were purified
and incorporated into dioleoyl phosphatidylcholine liposomes (Avanti Polar
Lipids) (Grakoui et al., 1999). The liposomes were placed on glass to form
planar bilayers and loaded overnight at 37C with 25 mMMCC in citrate buffer
(pH 4.5). All experiments in the planar bilayers were conducted with HEPES-
buffered saline containing 1% bovine serum albumin, 2 mM MgCl2, and
1 mM CaCl2.
Microscope Imaging
For confocal microscopy observation, a Leica TCS SP5 microscope with oil
immersion objective (HCX PL APO 633/1.40–0.60 NA, Leica) was used. For
Figure 2C, Figure S1A, and Figure S1B, we used STED microscopy with
a Leica DMI6000 B inverted microscope with oil immersion objective
(HCX PL APO 1003/1.40 OIL STED ORANGE, Leica). Images in Figure 2B
and Movie S3 were taken by TIRF microscopy (TIRFM) as previously
described (Tokunaga et al., 2008). We used another TIRFM systems for
other TIRF movies. An Olympus IX81 microscope with a TIRF objective
lens (Plan Apo N 603/1.45 NA, Olympus) with dual excitation lasers was
used.Quantitative Analysis of Imaging Data
For counting and evaluating TCR-MCs and cSMAC, G-count software
(G-Angstrom) and ImageJ were used.Electron Microscopic Analysis
Preparation of samples, examination, and analysis were performed by Kama-
kura Techno Science (Japan).SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures, nine movies and Supple-
mental Experimental Procedures and can be found with this article online at
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